Welcome to our dedicated page for Stevanato Group S P A SEC filings (Ticker: STVN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Stevanato Group S.p.A. filings document the company’s reporting as a foreign private issuer and its business in drug containment, drug delivery and diagnostic solutions. Form 6-K reports furnish interim financial statements, results press releases, investor presentations and conference call materials covering revenue trends, segment performance, high-value solutions, margins, guidance, capacity expansion and risk disclosures.
Governance filings also include shareholder meeting notices, explanatory reports, sustainability reporting, committee reports, remuneration policy materials, dividend allocation matters and director slate information. These documents describe the company’s financial reporting framework, board and committee processes, shareholder voting matters and public-company disclosures for STVN.
Stevanato Group S.p.A. director Karen Flynn filed an initial ownership report showing she holds 2,275 Ordinary Shares of the company. These shares are reported as held directly, and the filing does not reflect any recent purchase or sale, only her current stake.
Stevanato Group S.p.A. director William J. Federici has filed an initial statement of beneficial ownership, reporting holdings of the company’s ordinary shares. He reports 21,234 shares held directly and 31,589 shares held indirectly, described as being owned by his spouse and others. The filing records ownership positions rather than new share purchases or sales.
Stevanato Group S.p.A. director Alvise Spinazzi filed an initial Form 3 showing beneficial ownership of ordinary shares. The filing reports direct ownership of 3,300 ordinary shares after the reported holdings entry, with no specific buy or sell transactions disclosed in this statement.
Stevanato Group S.p.A. director Donald E. Morel Jr. filed an initial ownership report on Ordinary Shares. The Form 3 shows he directly owns 33,942 Ordinary Shares of the company. This filing establishes his baseline equity position as a board member rather than recording a new transaction.
Stevanato Group S.p.A.'s Chief Executive Officer, Franco Stevanato, filed an initial statement of beneficial ownership on Form 3. This filing establishes his status as an insider of the company but does not report any stock purchases, sales, or other transactions.
Stevanato Group S.p.A. director Sergio Stevanato filed an amended Form 3 insider ownership report. The amendment does not list any insider buy, sell, or derivative transactions, and the aggregated transaction summary shows neutral net activity with zero reported shares bought, sold, or exercised.
Stevanato Group S.p.A. director Lin Sue-Jean has filed an initial statement of beneficial ownership, reporting direct holdings of 2,000 Ordinary Shares. This Form 3 filing is a baseline disclosure of equity ownership for a company insider and does not report any recent share purchases or sales.
Stevanato Group S.p.A. director Balachandran Madhavan filed an initial ownership report showing his equity stake in the company. The filing indicates direct ownership of 65,976 Ordinary Shares of Stevanato Group S.p.A. following the reported position, providing a baseline view of his holdings as a company insider.
Stevanato Group S.p.A. director Sergio Stevanato filed an initial ownership report showing indirect beneficial ownership of 253,238,887 Class A Shares. These shares are held through Stevanato Holding S.r.l., reflecting a large stake reported as indirect ownership rather than directly in his own name.
Stevanato Group S.p.A. executive Mauro Stocchi filed an initial statement of beneficial ownership, reporting direct holdings of 404,942 Ordinary Shares. The filing also lists multiple grants of Restricted Share Units (RSUs), each convertible into one Ordinary Share at an exercise price of zero.
The RSU positions cover 2,470, 4,126, 6,160 and 14,016 underlying Ordinary Shares, with vesting schedules running over periods from January 2023–December 2025, January 2024–December 2026, January 2025–December 2027, and January 2026–December 2028, vesting in one or multiple installments after each vesting period ends.